首页 | 本学科首页   官方微博 | 高级检索  
     

原位心脏移植术后成活28个月
引用本文:许林海,孔颂阳,倪科伟. 原位心脏移植术后成活28个月[J]. 浙江临床医学, 2000, 2(1): 4-5,19
作者姓名:许林海  孔颂阳  倪科伟
作者单位:许林海(310014 浙江省人民医院)      孔颂阳(310014 浙江省人民医院)      倪科伟(310014 浙江省人民医院)      钱文伟(310014 浙江省人民医院)      朱 理(310014 浙江省人民医院)      严志焜(310014 浙江省人民医院)
摘    要:于1997年6月19日为一例终末期扩张心肌病患者施行了同种原位心脏移植术,至今存活质量良好。本例有四个特点:1。供体血HBsAg(+),HBeAb(+),HBcAb(+),术后病人无乙肝病毒感染征象;2.强调供心保护是手术成败的关键;3.采用国产赛斯平作为主要免疫抑制药物;4.术后小剂量免疫抑制药物联合抗排斥治疗,避免了严重并发症。

关 键 词:HBsAg 赛斯平 心脏移植术

A Report of one Case Lives for 28 Months after Orthotopic Heart Transplantation
Xu Linhai. A Report of one Case Lives for 28 Months after Orthotopic Heart Transplantation[J]. Zhejiang Clinical Medical Journal, 2000, 2(1): 4-5,19
Authors:Xu Linhai
Affiliation:Xu LInhai et al
Abstract:One patient with end - stage dilated cardiomyopathy was successfully treated by orthotopic heart transplantation on June, 1997 in our hospital. The patient has been living well and enjoying a high quality life since operation. There are four characteristics in this case: 1. The donor had positive serum HBsAg, HBeAb and HBcAb, but there is no evidence of hepatitis B infection on recipient afler transplantation. 2. Proper preservation of the donor heart is a key procedure for a successful transplantation. 3. Domestic Cyspin (CsA) was used as a main immunosuppressant. 4.Low doses triple immunosuppression therapy was effective in preventing rejection and other severe complications.
Keywords:Heart/Transplantation HBsAg Cyspin
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号